AutoCure is an EU funded research project within the FP6. Involved in the project are 26 different partners, of which 6 are industrial partners and 20 are from the acadeamia, from all over Europe. » read more

AutoCure at Eular

Also this year, for the fourth time, AutoCure had an exhibition booth at the Eular congress. The booth was frequently visited by both partners being part of the project, and also by very many other interested congress attendants. To download the posters used, please click here or the image below.

For more information material on the project, please find newsletters and brochures under News.

Parts of the project management,

Susanne Karlfeldt and Lars Klareskog.

COURSE

THE SCIENTIFIC BASIS OF RHEUMATOLOGY: A PRIMER FOR CLINICIANS

Athens, September 10-12, 2010

This special course will provide an overview of the current status of basic and clinical research in rheumatology, focusing particularly on developments in the past decade, during which there has been an explosion of new information in this field. Part of the lectures will focus on biologic processes underlying rheumatic diseases while the others will analyze developments in specific rheumatic diseases. This course will provide both researchers and clinicians with a comprehensive understanding of current knowledge on the scientific basis of rheumatology. For more information and preliminary program, please click here.

Members of the AutoCure consortium
have, for the first time, shown a link
between genes, smoking and specific
autoimmunity in the development of RA

In November 2009 researchers from The Kennedy Institute of Rheumatology in London and Karolinska Institutet in Stockholm published the article ”Specific interaction between genotype, smoking and autoimmunity to citrullinated a-enolase in the etiology of rheumatoid arthritis” in Nature Genetics. This is one of the most significant proofs so far of the strong gene-environment interaction that underlies the development of RA.

Nat Genet. 2009 Dec;41(12):1319-24

The article is a good proof of the excellent and successful collaboration"
(Karin Lundberg, PhD, Karolinska Institutet, Stockholm)
.....
"One of the most important publications within the AutoCure project so far"
(Professor Lars Alfredsson, Karolinska Institutet, Stockholm)

"Both screening and prevention is much needed"
( Professor Patrick Venables, The Kennedy Institute of Rheumatology, London)

"The importance of AutoCure in research is large"
(Peter Charles, Clinical Immunologist, The Kennedy Institute of Rheumatology, London)
....

"Free radicals seem to have a positive impact on the immune defense system"(Peter Olofsson, CEO Redoxis)

For more interesting quotes and articles, please read the latest issue of the newsletter AutoCurious here

Gaining more knowledge on early diagnosis and early treatment of RA

AutoCure has now passed its three year anniversary, and many programs are in their most active phase, and will remain so during the coming two years. Looking both on what has been accomplished and even more on what can be achieved in the remaining time, AutoCure coordinator Lars Klareskog wants to highlight a few accomplishments as well as a few urgent needs: Read more

Unique chance to study the early mechanisms of RA

Catch RA-patients very early,
treat them aggressively and
do thorough regular follow
ups with ultrasound. That’s the
treatment recipe currently being
developed by the Rheumatology
Research Group (RRG)
at Birmingham University. Read more

Professor Chris Buckley

Early treatment standard in Vienna

Early treatment is not a new concept at the Vienna General Hospital (AKV) in Austria. AutoCure partner professor Josef Smolen
was among the first rheumatologists in Europe to open an early arthritis clinic 15 years ago. Many studies on outcome of RA
have provided his research group with convincing evidence that early and aggressive treatment is successful – more than 25 percent of the patients treated here are in full remission. Read more.

Professor Josef Smolen

Possible new treatment concept for early RA

Associate professor of biochemistry Günter Steiner is the only group leader in professor Josef Smolens research team who is a 100 percent basic science researcher. Read more

Professor Guenter Steiner

Regular exercise can reduce inflammation

New studies now confirm that moderate regular exercise is very beneficial for Myositispatients – and most likely also
for other inflammatory diseases. In the near future exercise could be made a common prescription ”drug”. Read more.

Professor Ingrid Lundberg